QT
MRNS

Quantbot Technologies’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Quantbot Technologies’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,800
Closed -$11K – 2213
2022
Q3 		$11K Sell
1,800
-1,700
-49% -$10.5K ﹤0.01% 1419
2022
Q2 		$16K Sell
3,500
-800
-19% -$4.87K ﹤0.01% 1480
2022
Q1 		$40K Buy
+4,300
New +$42.7K ﹤0.01% 1245
2021
Q4 		– Sell
-400
Closed -$4K – 2012
2021
Q3 		$4K Buy
+400
New +$5.5K ﹤0.01% 1427
2018
Q2 		– Sell
-537
Closed -$8K – 1560
2018
Q1 		$8K Sell
537
-1,507
-74% -$35.9K ﹤0.01% 1128
2017
Q4 		$66K Buy
+2,044
New +$55.1K 0.01% 932

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

Quantbot Technologies's MRNS Position: Q4 2022 in Review

Quantbot Technologies sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2022, closing a stake of 1,800 shares — an estimated $11K sold.

Quantbot Technologies first reported a position in MRNS in Q4 2017 and held it in 6 quarters. The position peaked at $66K in Q4 2017. 74 funds tracked by Wall St. Rank hold MRNS as of Q4 2022.

  • Quantbot Technologies reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 1,800 Marinus Pharmaceuticals, Inc shares in Q4 2022, an estimated $11K.
  • Quantbot Technologies first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 6 quarters.
  • Quantbot Technologies's Marinus Pharmaceuticals, Inc position peaked at $66K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.